1.Is Intraperitoneal Chemotherapy Dead?.

2.Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer.

3.Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer.

4.CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer.

5.Internal Herniation in Pregnancy After Gastric Bypass: A Systematic Review.

6.Association of First-Trimester Echogenicity of the Puborectalis Muscle With Mode of Delivery.

7.Risk of Preeclampsia in Human Immunodeficiency Virus-Infected Pregnant Women.

8.Evaluation of an Electronic Consultation Service in Obstetrics and Gynecology in Ontario.

9.The Goldilocks Quandary of Health Care Resources: Too Little, Too Much, or Just Right?.

10.Prevalence of Endometriosis During Abdominal or Laparoscopic Hysterectomy for Chronic Pelvic Pain.

11.Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers: Estimating Ovarian Cancer Risk.

12.Double Aneuploidy Detected by Cell-Free DNA Testing and Confirmed by Fetal Tissue Analysis.

13.Profound Hyperthermia After Postpartum Rectal Misoprostol Administration.

14.Quality of Life and Sexual Function 2 Years After Vaginal Surgery for Prolapse.

15.Episode-Based Payment for Perinatal Care in Medicaid: Implications for Practice and Policy.

16.Prevention, Recognition, and Management of Urologic Injuries During Gynecologic Surgery.

17.The Exclusion of Sperm Donation on the Basis of Sexual Practices: Time for a Policy Update.

18.Gestational Age of Delivery in Pregnancies Complicated by Chronic Hypertension.

19.Medical Device Approvals Through the Premarket Approval Pathway in Obstetrics and Gynecology From 2000 to 2015: Process and Problems.

20.Clinical Characteristics and Management of Neovaginal Fistulas After Vaginoplasty in Transgender Women.

21.Preterm Delivery and Metabolic Syndrome in Women Followed From Prepregnancy Through 25 Years Later.

22.Using Bundled Interventions to Reduce Surgical Site Infection After Major Gynecologic Cancer Surgery.

23.Patient-Health Care Provider Conversations About Prenatal Genetic Screening: Recommendation or Personal Choice.

24.Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System.

25.Pain and Analgesia During Labor and Delivery Between 16 0/7 and 22 6/7 Weeks of Gestation.

26.What Is New in Long-Acting Reversible Contraception?: Best Articles From the Past Year.

27.Connect the Dots-June 2016.

28.Preterm Breech Presentation: A Comparison of Intended Vaginal and Intended Cesarean Delivery.

29.Trying to Conceive After an Early Pregnancy Loss: An Assessment on How Long Couples Should Wait.

30.In Reply.

31.Same-Day Discharge After Minimally Invasive Myomectomy: Correction.

32.Checklist.

33.Author Agreement.

34.Table of Contents June 2016 Issue.

35.College Publications.

36.Practice Bulletin No. 164 Summary: Diagnosis and Management of Benign Breast Disorders.

37.Obstetric Care Consensus No. 4 Summary: Periviable Birth.

38.Committee Opinion No. 663 Summary: Aromatase Inhibitors in Gynecologic Practice.

39.Committee Opinion No. 664 Summary: Refusal of Medically Recommended Treatment During Pregnancy.

40.Committee Opinion No. 665 Summary: Guidelines for Adolescent Health Research.

41.Committee Opinion No. 666 Summary: Optimizing Postpartum Care.

42.Author Agreement.

43.Obstetric Care Consensus No. 4: Periviable Birth.

44.Committee Opinion No. 663: Aromatase Inhibitors in Gynecologic Practice.

45.Committee Opinion No. 664: Refusal of Medically Recommended Treatment During Pregnancy.

46.Committee Opinion No. 665: Guidelines for Adolescent Health Research.

47.Committee Opinion No. 666: Optimizing Postpartum Care.